Cenergy Holdings S.A. (0RL2)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 22.40 |
|---|---|
| 52-week range | 13.44 – 27.91 |
| Return, 1 month / 3 months | −4.4% / +7.7% |
| Return, 1 year / 3 years | +68.2% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 47.7% |
| Worst drawdown (1 year) | -27.1% |
| Average daily value traded | 0.20M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cenergy Holdings is a holding company whose subsidiaries make cables and steel pipes. Its cable business produces power cables for land and subsea use, along with telecommunications cables, serving utilities, grid operators and energy projects. Its pipe business manufactures steel pipes for oil and gas pipelines and offshore applications, supplying energy companies and pipeline contractors. The company is based in Belgium, with its operating plants and main activities centred in Greece, and it serves customers in energy and infrastructure markets internationally.
Cenergy Holdings S.A. trades under the code 0RL2 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cenergy Holdings S.A. (0RL2) trades on the London Exchange in UK. It last closed at EUR 22.40 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,848 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 68.2% and over the last three months it rose 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.8% | ||
| From 52-week high | -17.8% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.7% | ||
| 6-month return | 9.9% | ||
| 12-month return, skipping the last month | 76.0% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 47.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.1% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.20M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 4 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.2% |
|---|---|
| 1 month | −4.4% |
| 3 months | +7.7% |
| 6 months | +9.9% |
| 1 year | +68.2% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 22.99 / 21.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 0.2600 |
| 24 Jun 2025 | EUR 0.0980 |
| 25 Jun 2024 | EUR 0.0560 |
| 19 Jun 2023 | EUR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.